您好，欢迎来到半岛电竞官方网址 ！ [登录] [免费注册]
半岛电竞官方网址
发布求购
位置：首页 > 半岛bd体育手机客户端 库 > Daratumumab
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
Daratumumab
本半岛bd体育手机客户端 不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
CAS NO:945721-28-8
包装与价格：
包装价格(元)
1mg电议
5mg电议
10mg电议
50mg电议

半岛bd体育手机客户端 名称
达雷木单抗
Anti-Human CD38, Human Antibody
半岛bd体育手机客户端 介绍
Daratumumab (Anti-Human CD38) 是首创的特异性抗CD38单克隆抗体 (IgG1)。Daratumumab 具有抗多发性骨髓瘤(MM) 的作用。Daratumumab 损伤了 MM 细胞的粘附，从而增加了 MM 对蛋白酶体抑制的敏感性。
生物活性

Daratumumab (Anti-Human CD38) is the first-in-class human-specificanti-CD38monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM toproteasomeinhibition[1][2].

体外研究
(In Vitro)

Daratumumab (Anti-Human CD38) induces potent Ab-dependent cellular cytotoxicity in CD38-expressing lymphoma- and MM-derived cell lines[2].

体内研究
(In Vivo)

Daratumumab (i.p.; 0.5 mg/kg; 14 d after challenge with Daudi-luc cells) inhibits outgrowth of CD38-expressing tumor cells in mouse xenograft tumor models[2].

Animal Model:8- to 10-wk-old C.B-17 SCID mice (luciferase-expressing Daudi cells)[2]
Dosage:0.5 mg/kg
Administration:I.p.; 14 day after challenge with Daudi-luc cells
Result:Effectively inhibited tumor growth compared with control-treated animals in which tumor grew rapidly and therefore required euthanasia on day 35. On day 28 and day 35, tumor size in Daratumumab-treated animals was significantly different from the control.
Clinical Trial
性状

Liquid

CAS 号

945721-28-8

中文名称

达雷妥尤单抗； 达妥木单抗

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

Baidu
map